HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.
about
Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humansStem-cell-based gene therapy for HIV infectionSAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cellsTargeted DNA mutagenesis for the cure of chronic viral infectionsIntegrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo AcidsQuantification of viral infection dynamics in animal experimentsHIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesUsing mouse models to study function of transcriptional factors in T cell developmentPredictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approachCrystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4Peering below the diffraction limit: robust and specific sorting of viruses with flow cytometryTherapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTImpact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infectionThe NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytesPhosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytesDendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitorsHepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agentsA Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNPLong lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.Nanotechnology and HIV: potential applications for treatment and prevention.HIV prevention transformed: the new prevention research agendaAn old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV.A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase metabolism profile.Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells.Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsHuman Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryEpigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation.Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment.Pharmacokinetics and dose-range finding toxicity of a novel anti-HIV active integrase inhibitor.Efficient identification of human immunodeficiency virus type 1 mutants resistant to a protease inhibitor by using a random mutant library.BET bromodomain inhibition as a novel strategy for reactivation of HIV-1Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1The colocalization potential of HIV-specific CD8+ and CD4+ T-cells is mediated by integrin β7 but not CCR6 and regulated by retinoic acid.Transcriptional provirus silencing as a crosstalk of de novo DNA methylation and epigenomic features at the integration siteHyperthermia stimulates HIV-1 replicationImmune interventions in HIV infection.Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infectionNonhuman primate models for HIV cure research.
P2860
Q21560816-3F3897A9-7FF9-49C5-A81D-D83EE1949CD6Q24607667-9F13E0A9-B622-4154-9EA4-B1D9506F8464Q24615124-13369635-4E54-4069-946F-D167F6261AD4Q24620150-800CAC3B-BAC6-4DA3-B518-C16F692826F0Q26800036-358993DA-09E4-4A44-95BE-928CF8FA80AAQ26824804-D9D6D1E7-2194-4436-9871-027F494510B5Q26825087-6BFC728B-0A90-40C1-8ED9-B5D898361D3AQ27011507-F12B1B28-F952-46E0-AF04-BC4224FDE1DAQ27324340-0A51F4F5-43A7-426E-B1C8-C467AE793C6FQ27683254-7C534738-1C88-4E8B-A941-626179348C7BQ28119691-FC58AEB6-B385-4A17-8C30-282A269A4480Q28476094-603227F6-A5AA-4291-80BE-C884E4A6D9B9Q28481938-96ED06A3-DBF3-4FB6-94C3-8203B392CDB2Q28486204-F94939F2-C756-4F6D-B456-B3EC7A3F12F6Q28487524-DAFA3A8A-66C5-4CE9-9CDE-883FBFB6F59DQ28534580-B4BAEFCB-F3A5-4315-BD37-BB6B2B220403Q28538891-F2F94E00-50F8-4074-BB32-F118F21ABB7DQ28550986-534C9DD2-A295-4A5B-9255-63A81BC40AFDQ30373903-FB6C127A-BDA2-4FA4-BB6B-53E35B7223E2Q30393980-E8ECDB3E-A86C-452A-B4E9-40862ED5EDFEQ30404963-4BC5ADFF-9FB2-4259-8E7A-1692753ED09DQ30407263-93F19CEF-D5A2-4FEE-8576-902B24F177C2Q30429621-0600C36D-563F-4A53-BF45-4915E80D33C7Q31036545-5BDF4826-5499-47B8-8C05-D1CCA219CA95Q33575261-DBA99389-78A9-4740-BBBB-5B9B8B07358BQ33742139-FC59541A-A680-476A-B7CC-0DBFDEACA4E0Q33768729-9F6C9CDF-4805-4D45-967A-132F916A1855Q33771155-2EC549A3-EAFF-45D4-80F7-6C2BF3CFE595Q33869222-C359D22C-156C-4F40-ADDC-4C147DEA02DEQ33900251-94A11013-9E67-4CB6-8484-0325C10DC499Q33911400-7E24E1AD-6473-4CFD-8FDE-DC60243E0A34Q34005107-126EA381-4021-4475-B77F-2CBE61FB1969Q34032827-82FAAFD3-49DC-4A83-9622-49DD8BAEB6E2Q34132738-AF685C62-6EEE-4255-8CD8-502B224161C3Q34217360-1FAB9B9A-864B-4432-9E8E-AE2063B5DFA6Q34257867-0AFC304C-C748-4956-9F52-C482DC67A6C7Q34341364-524F0D49-07EE-47BB-9DB2-4E4D3BE84C6DQ34351326-6F73945A-AE03-4732-B61E-CD767B22CCE4Q34405543-977C7DC2-1749-4C82-B058-FF81B5FF410FQ34407781-9F84ABA7-CAAB-4008-8F73-79EA80D2935C
P2860
HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV persistence and the prospe ...... for HIV-infected individuals.
@en
HIV persistence and the prospe ...... for HIV-infected individuals.
@nl
type
label
HIV persistence and the prospe ...... for HIV-infected individuals.
@en
HIV persistence and the prospe ...... for HIV-infected individuals.
@nl
prefLabel
HIV persistence and the prospe ...... for HIV-infected individuals.
@en
HIV persistence and the prospe ...... for HIV-infected individuals.
@nl
P2860
P50
P356
P1433
P1476
HIV persistence and the prospe ...... for HIV-infected individuals.
@en
P2093
Didier Trono
P2860
P304
P356
10.1126/SCIENCE.1191047
P407
P577
2010-07-01T00:00:00Z